- £3.47bn
- £3.97bn
- £2.98bn
- 70
- 48
- 20
- 40
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,884 | 1,954 | 2,003 | 2,554 | 2,982 |
Cost of Revenue | |||||
Gross Profit | 839 | 855 | 856 | 1,128 | 1,352 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,683 | 1,749 | 1,836 | 2,245 | 2,599 |
Operating Profit | 201 | 205 | 167 | 309 | 383 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 195 | 200 | 161 | 302 | 372 |
Provision for Income Taxes | |||||
Net Income After Taxes | 148 | 155 | 126 | 230 | 285 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 148 | 155 | 126 | 230 | 285 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 148 | 155 | 126 | 230 | 285 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.358 | 0.35 | 0.329 | 0.49 | 0.612 |
Dividends per Share |